# US Predictive Disease Analytics Market

> US Predictive Disease Analytics Market Research Report By Component (Software & Services, Hardware), By Deployment (On-premise, Cloud-based) and By End User (Healthcare Payers, Healthcare Providers, Other End Users) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.77%
- **2024:** $ 896.91 Million
- **2025:** $ 984.54 Million
- **2035:** $ 2,500 Million
- **Key Players:** IBM (US), Cerner Corporation (US), Epic Systems Corporation (US), McKesson Corporation (US), Optum (US), Philips (NL), Siemens Healthineers (DE), Roche Diagnostics (CH), Allscripts Healthcare Solutions (US)

**Report ID:** MRFR/HC/14128-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-predictive-disease-analytics-market-15655

---

## Market Summary

## **US Predictive Disease Analytics Market Overview**

As per MRFR analysis, the US Predictive Disease Analytics Market Size was estimated at 727.27 (USD Million) in 2023. The US Predictive Disease Analytics Market Industry is expected to grow from 896(USD Million) in 2024 to 8,903.42 (USD Million) by 2035. The US Predictive Disease Analytics Market CAGR (growth rate) is expected to be around 23.214% during the forecast period (2025 - 2035).

### **Key US Predictive Disease Analytics Market Trends Highlighted**

The US Predictive Disease Analytics Market is experiencing significant growth due to several key market drivers. These include the increasing prevalence of chronic diseases, which compels healthcare providers and payers to adopt advanced analytics to improve patient outcomes. Additionally, regulatory initiatives promoting the use of health information technology bolster the demand for predictive analytics to enhance care delivery and reduce costs. Recent advancements in artificial intelligence and machine learning further enable healthcare institutions to analyze vast amounts of data effectively, leading to more accurate predictions of disease outbreaks and patient trends.

Opportunities to be explored in the US market include the integration of predictive analytics with telehealth solutions, which gained traction during the COVID-19 pandemic. As remote patient monitoring expands, there is a growing need for tools that can predict potential health issues based on real-time data collected from patients’ home environments. Furthermore, public health agencies are increasingly leveraging predictive analytics to model disease trends and allocate resources efficiently, signaling a demand for collaboration between technology firms and health organizations.

Trends in recent times show a strong focus on interoperability among healthcare systems to enhance data sharing and facilitate better predictive modeling. This push is also supported by initiatives such as the 21st Century Cures Act, which aims to improve patient access to healthcare data. There is also an emphasis on patient-centered care, as providers increasingly seek to engage patients through personalized health insights derived from predictive models. Overall, the US Predictive Disease Analytics Market is poised for expansion driven by technological innovation, regulatory support, and changing patient dynamics.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Predictive Disease Analytics Market Drivers**

### **Increasing Demand for Personalized Medicine**

The US Predictive Disease Analytics Market Industry is significantly driven by the increasing demand for personalized medicine. According to current trends, the National Institutes of Health (NIH) has reported a substantial increase in the expenditure on personalized medicine research, which exceeded 80 billion USD in recent years. This emphasis highlights the market's shift towards individualized treatment plans, leveraging analytics to enhance patient outcomes.

Major organizations such as the Mayo Clinic and Cleveland Clinic are at the forefront, developing predictive algorithms that can accurately forecast patient responses to various treatments. The application of predictive analytics can lead to better-targeted therapies, reducing trial-and-error in treatment plans, which is particularly crucial given the reported annual costs of up to 350 billion USD associated with ineffective medication in the US.

As healthcare providers strive to improve patient satisfaction while managing costs, the growth of predictive analytics tools for disease management becomes increasingly crucial, ensuring that the US Predictive Disease Analytics Market continues to thrive.

### **Rapid Advancements in Technology**

Technological advancements play a key role in propelling the US Predictive Disease Analytics Market Industry forward. The integration of Artificial Intelligence (AI) and machine learning algorithms in healthcare analytics has seen significant growth, with AI investments in the healthcare sector expected to reach 35 billion USD by 2025. Established organizations like IBM Watson Health and Google Health are leading the charge, implementing AI solutions that enhance diagnostics and predictive modeling capabilities.

Such advancements allow healthcare providers to analyze vast amounts of patient data rapidly, leading to more accurate predictions of disease outbreaks and patient health trends. The US healthcare system's digitalization further supports this growth, directly linking technology and predictive analytics to improve patient care quality and operational efficiency.

### **Growing Prevalence of Chronic Diseases**

The rising prevalence of chronic diseases in the United States acts as a significant market driver for the US Predictive Disease Analytics Market Industry. Data from the Centers for Disease Control and Prevention (CDC) indicates that approximately 60% of adults have a chronic disease, significantly influencing healthcare costs that exceed 3 trillion USD annually. This alarming statistic underlines the need for improved predictive capabilities to manage chronic disease effectively.

Organizations like the American Heart Association are increasingly collaborating with analytics firms to develop predictive models aimed at preventing and managing conditions like diabetes and heart disease. The demand for effective predictive analytics solutions is amplified by the need to optimize resource allocation and improve patient outcomes, thereby fueling the market's growth potential in the coming years.

### **Implementation of Government Policy Changes**

Government policy changes are exerting a substantial influence on the US Predictive Disease Analytics Market. Recent healthcare reforms, including the Affordable Care Act, have raised the demand for data-driven decision-making in patient care. Such reforms encourage the use of predictive analytics to enhance efficiency in healthcare delivery, with government funds significantly invested in health information technology initiatives.

For instance, multiple federal agencies, including the Health Resources and Services Administration (HRSA), have initiated programs dedicated to improving health outcomes through data analytics. This increased focus on analytics not only assists healthcare providers in adhering to new regulations but also enables them to implement strategies that prevent disease outbreaks, thereby directly impacting market growth.

## **US Predictive Disease Analytics Market Segment Insights**

### **Predictive Disease Analytics Market Component Insights**

The Component segment of the US [Predictive Disease Analytics](../../../reports/predictive-disease-analytics-market-11853) Market encompasses critical elements such as Software and Services, as well as Hardware, which play a vital role in enhancing healthcare delivery and decision-making processes. Software solutions in this market are predominantly focused on data analytics, machine learning, and artificial intelligence, enabling healthcare professionals to predict disease outbreaks, assess risk factors, and analyze patient data efficiently. The surge in data generation from various healthcare sources, including electronic health records and wearable devices, has significantly increased the reliance on advanced software tools that can process and interpret large volumes of data.

In parallel, Services provided within the Component segment, including consulting, implementation, and maintenance, are essential for ensuring that healthcare institutions can effectively integrate and utilize predictive analytics tools, thereby enhancing overall operational efficiency and patient outcomes. On the other hand, Hardware components remain equally significant by providing the necessary infrastructure to support the advanced software applications that dominate this industry. The growth of cloud computing and increased adoption of medical devices facilitate the deployment of predictive analytics in real-time settings.

This convergence of hardware and software delivers a comprehensive solution that maximizes the potential of predictive analytics by allowing seamless data transfer, storage, and processing capabilities. As the US continues to invest in healthcare technology infrastructure, the demand for integrated software and hardware solutions is anticipated to rise, further driving innovation in the Predictive Disease Analytics Market.

The integration of these components enables healthcare providers to not only improve patient care but also manage resources more effectively and predict future healthcare trends in a rapidly evolving landscape. The ongoing advancements in technology, alongside a growing emphasis on proactive healthcare, foster a strong growth environment for the Component segment within the US Predictive Disease Analytics Market, highlighting its pivotal role in shaping the future of healthcare analytics.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Predictive Disease Analytics Market Deployment Insights**

The Deployment segment of the US Predictive Disease Analytics Market is crucial for facilitating the effective use of analytics solutions in healthcare. This segment is primarily categorized into On-premise and Cloud-based deployments, both of which cater to the varying needs of healthcare organizations. On-premise solutions offer a greater degree of control and security, appealing to institutions that manage sensitive patient data.

Conversely, Cloud-based deployments provide flexibility and scalability, enabling healthcare providers to rapidly adjust to changing demands, which is particularly important in an industry where rapid data processing can enhance patient outcomes. With the increasing emphasis on data-driven decision making in the US healthcare landscape, the demand for both deployment types is expected to rise steadily.

As organizations seek to leverage advanced analytics for predictive insights, the ability to choose between On-premise and Cloud-based solutions allows them to align their strategies with their unique operational requirements and compliance obligations. The continuous innovation and integration of Artificial Intelligence and Machine Learning techniques into these platforms further drive the market growth by improving accuracy in disease prediction and patient management. Therefore, the Deployment segment plays a significant role in shaping the US Predictive Disease Analytics Market through its contributions toward effective data utilization and enhanced healthcare delivery.

### **Predictive Disease Analytics Market End User Insights**

The US Predictive Disease Analytics Market shows significant growth potential across various End User categories, indicating a robust demand for advanced analytic solutions. Healthcare Payers, including insurance companies, are increasingly investing in predictive analytics to optimize cost management and enhance patient outcomes, as they rely on data-driven insights for efficient claims processing and risk assessment. Healthcare Providers are also embracing predictive analytics to improve clinical decision-making and patient care, focusing on preventing disease progression and resource allocation.

Additionally, Other End Users, such as pharmaceutical companies and researchers, leverage predictive technologies to streamline drug development processes and address public health challenges, ensuring better patient access to treatments. The market dynamics are influenced by factors like technological advancements, increasing healthcare data availability, and a rise in chronic disease prevalence across the US.

As the industry matures, improved methodologies and regulatory support are expected to further drive the adoption of predictive disease analytics among these diverse End Users, contributing to a more efficient healthcare ecosystem. These segments play a crucial role in shaping the US Predictive Disease Analytics Market landscape, driving innovations and paving the way for tailored healthcare solutions.

## **US Predictive Disease Analytics Market Key Players and Competitive Insights**

The US Predictive Disease Analytics Market is witnessing rapid growth driven by advancements in data analytics technology and an increasing need for preventive healthcare. This market encompasses a range of tools and techniques designed to forecast disease outbreaks, identify at-risk populations, and improve patient outcomes through data-driven insights. The competitive landscape is characterized by a blend of established players and emerging startups, all vying for a share of the expanding market. Companies leverage artificial intelligence, machine learning, and big data to enhance their predictive capabilities, making it crucial for organizations to stay ahead of technological trends and innovations.

The interplay of these market dynamics creates a highly competitive environment where firms must differentiate themselves through unique product offerings, cutting-edge technology, and strategic collaborations.

SAP has established a noteworthy presence in the US Predictive Disease Analytics Market, recognized for its integrated solutions that facilitate real-time data analysis and decision-making in healthcare. The company’s software offerings, designed to analyze health-related data and improve operational efficiency, are pivotal for healthcare organizations looking to harness predictive analytics. SAP's strengths lie in its robust technological infrastructure and a strong emphasis on data integrity and security, which is particularly crucial in handling sensitive health information.

Furthermore, SAP's ability to integrate seamlessly with existing IT infrastructures of healthcare organizations enhances its appeal in the market, as clients seek efficient and scalable solutions that can adapt to their evolving needs. The firm’s commitment to research and development continuously fuels its innovation pipeline, further solidifying its competitive edge. SAS is another leading player in the US Predictive Disease Analytics Market, renowned for its advanced analytics software and services tailored for healthcare providers.

The company offers a suite of products that focus on predictive modeling and patient analytics, empowering healthcare providers to anticipate patient needs and improve clinical outcomes. SAS's strong market presence is underscored by its extensive collaborations with healthcare institutions and commitment to building partnerships that drive innovation in predictive analytics. The company’s strengths include a rich legacy of expertise in statistical analysis and data mining, alongside a user-friendly interface that enables healthcare professionals to extract insights with ease.

Moreover, SAS has been actively engaging in mergers and acquisitions to bolster its capabilities and broaden its service offerings in the predictive analytics space, enhancing its competitive position within the US market.

### **Key Companies in the US Predictive Disease Analytics Market Include**

## **US Predictive Disease Analytics Market Industry Developments**

In recent months, the US Predictive Disease Analytics Market has seen significant developments, notably in healthcare analytics solutions provided by companies such as SAP, SAS, and Oracle. Innovations focused on enhancing patient outcomes through predictive modeling and data analysis are gaining traction. In July 2023, Cerner was reported to have expanded its predictive analytics capabilities by integrating machine learning tools to enhance hospital operations and patient care. Furthermore, in August 2023, Allscripts announced a strategic partnership with Health Catalyst to deliver advanced data integration services which could improve clinical decision-making processes.

The investment activity in this sector remains robust, with UnitedHealth Group acquiring a stake in Inovalon in September 2023 to leverage predictive capabilities that can enhance insurance and healthcare management. Additionally, IBM's acquisition of a smaller analytics firm in June 2023 aimed to strengthen its healthcare AI portfolio, allowing for deeper patient insights. The valuation of major players in the market is increasing, with estimates suggesting a rapid growth trend, underlining the importance of predictive analytics in addressing healthcare challenges across the United States.

Recent market growth has emphasized the role of technology in managing public health data and improving responses to disease outbreaks.

## **US Predictive Disease Analytics Market Segmentation Insights**

### **Predictive Disease Analytics Market Component Outlook**

### **Predictive Disease Analytics Market Deployment Outlook**

### **Predictive Disease Analytics Market End User Outlook**

## Market Drivers

### Growing Awareness of Chronic Diseases

The rising awareness of chronic diseases is a significant driver for the predictive disease-analytics market. As the prevalence of conditions such as diabetes and heart disease continues to escalate, there is a pressing need for effective management strategies. Predictive analytics can help identify individuals at risk and facilitate early interventions, potentially reducing the burden on healthcare systems. Recent studies indicate that chronic diseases account for approximately 75% of healthcare spending in the US. This alarming statistic underscores the necessity for predictive disease-analytics solutions, which are likely to gain traction as healthcare providers seek to mitigate the impact of chronic illnesses.

### Integration of Big Data in Healthcare

The integration of big data into healthcare systems is transforming the predictive disease-analytics market by enabling the analysis of vast amounts of health-related data. With vast amounts of health-related data generated daily, the ability to analyze and interpret this information is crucial. Big data analytics allows for the identification of trends and patterns that can inform clinical decision-making. The healthcare big data market is projected to reach $68 billion by 2025, highlighting the increasing reliance on data-driven insights. As healthcare organizations adopt big data technologies, the predictive disease-analytics market is likely to experience significant growth, driven by the demand for enhanced analytical capabilities.

### Rising Demand for Personalized Medicine

The increasing emphasis on personalized medicine is a pivotal driver for the predictive disease-analytics market. As healthcare shifts towards tailored treatment plans, predictive analytics plays a crucial role in identifying individual patient needs. This trend is evidenced by a projected growth rate of 25% in the personalized medicine sector by 2027. The ability to analyze genetic, environmental, and lifestyle factors allows healthcare providers to predict disease susceptibility and treatment responses more accurately. Consequently, the predictive disease-analytics market is likely to expand as healthcare systems adopt these advanced analytics to enhance patient outcomes and optimize resource allocation.

### Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare significantly drives the predictive disease-analytics market by prioritizing strategies that focus on prevention rather than treatment. As healthcare costs continue to rise, stakeholders are prioritizing strategies that focus on prevention rather than treatment. Predictive analytics enables healthcare providers to identify at-risk populations and implement early intervention strategies. This shift is reflected in a 15% increase in funding for preventive health programs over the past few years. By utilizing predictive analytics, healthcare systems can reduce hospital admissions and improve overall population health, thereby fostering growth in the predictive disease-analytics market.

### Advancements in Data Collection Technologies

Technological advancements in data collection are significantly influencing the predictive disease-analytics market. The proliferation of wearable devices and mobile health applications enables continuous monitoring of patient health metrics. This influx of real-time data enhances the accuracy of predictive models, allowing for timely interventions. According to recent estimates, the wearable technology market is expected to reach $60 billion by 2025, indicating a robust growth trajectory. As healthcare providers increasingly leverage these technologies, the predictive disease-analytics market is poised for substantial growth, driven by the demand for more precise and actionable health insights.

## Future Outlook

The [Predictive Disease Analytics Market](https://www.marketresearchfuture.com/reports/predictive-disease-analytics-market-11853) is projected to grow at a 9.77% CAGR from 2025 to 2035. This growth is driven by advancements in AI, data integration, and personalized healthcare solutions.

**New opportunities:**

- Development of AI-driven predictive modeling tools for chronic disease management. Integration of real-time data analytics in telehealth platforms. Partnerships with healthcare providers for customized analytics solutions.

By 2035, the market is expected to achieve substantial growth, enhancing healthcare delivery and patient outcomes.

## Segment Insights

### By Component: Software & Services (Largest) vs. Hardware (Fastest-Growing)

In the US predictive disease-analytics market, the component segment is dominated by Software & Services, which hold the largest market share due to their critical role in data analysis and supporting decision-making processes in healthcare settings. Software solutions are increasingly being integrated with advanced analytics and machine learning capabilities, making them essential for predictive modeling, visualization, and operational efficiency. On the other hand, the Hardware segment, while smaller, is identified as the fastest-growing segment. This growth is propelled by the increasing demand for enhanced computational power and storage solutions necessary for effective handling of large datasets in healthcare.

The trends driving growth in the Software & Services segment include the rising adoption of cloud-based solutions and the continuous advancements in AI and machine learning technologies. Healthcare institutions are increasingly investing in predictive analytics to optimize patient outcomes and streamline operations, further boosting this segment. In contrast, the Hardware segment is experiencing rapid development due to innovations in processing speeds, data storage systems, and integration with IoT devices. As healthcare data becomes more extensive and complex, the need for robust hardware infrastructure to support real-time analytics and operational applications grows.

Software & Services (Dominant) vs. Hardware (Emerging)

Software & Services represent the dominant force in the US predictive disease-analytics market, distinguished by a growing reliance on AI-driven analytics and user-friendly interfaces that facilitate healthcare providers' adoption. This segment encompasses a broad spectrum of applications, including EHR integrations, patient management systems, and data visualization tools, which collectively enhance operational efficiency and decision-making capabilities. Meanwhile, Hardware is classified as an emerging segment, driven by ongoing trends like the increasing demand for high-performance computing systems and advanced data storage solutions. The rise of cloud computing and IoT adoption is influencing hardware providers to innovate, ensuring they can deliver the necessary technology to support sophisticated predictive analytics tasks.

### By Deployment: Cloud-based (Largest) vs. On-premise (Fastest-Growing)

In the US predictive disease-analytics market, the distribution of market share between deployment models shows a clear preference for cloud-based solutions, which currently dominate the segment. This is driven by their scalability, cost-effectiveness, and ease of integration with existing health informatics frameworks. Meanwhile, on-premise solutions have captured a smaller share but are quickly gaining traction as healthcare institutions prioritize data ownership and security in their analytics processes.

The growth trends for this segment indicate an increasing shift towards cloud-based deployments as organizations seek to leverage advanced analytics without the burden of maintenance and infrastructure costs. However, the on-premise segment is the fastest-growing, driven by security concerns and compliance needs among health providers. Many organizations are investing in on-premise solutions to better control their data and ensure patient privacy, creating a dynamic ecosystem for competitive growth in both deployment types.

Deployment: Cloud-based (Dominant) vs. On-premise (Emerging)

Cloud-based deployments in the US predictive disease-analytics market are characterized by their extensive capabilities in processing vast amounts of health data with high efficiency. The convenience of remote access and lower initial costs makes them the dominant choice for many healthcare providers. In contrast, on-premise solutions, while representing a smaller share, are emerging rapidly. They offer institutions enhanced control over their data and compliance with stringent regulatory requirements, appealing to organizations with specific security standards. As the demand for secure and accessible analytics grows, both deployment types will continue to play critical roles, catering to diverse needs and preferences in the healthcare sector.

### By End User: Healthcare Payers (Largest) vs. Healthcare Providers (Fastest-Growing)

In the US predictive disease-analytics market, the segment distribution shows that healthcare payers hold the largest share, driven by their significant investment in technologies that enhance patient outcome predictions. They leverage analytics to strategically manage healthcare costs while improving service efficiency. On the other hand, healthcare providers are rapidly gaining ground, focusing on personalized care approaches and data-driven decision-making to optimize patient care plans, thus catering to the increasing demand for predictive solutions.

The growth trends indicate a robust expansion in the healthcare providers segment, fueled by technological advancements and an emphasis on integrated healthcare services. Providers are increasingly adopting predictive analytics tools to streamline processes, reduce readmission rates, and enhance patient engagement. Furthermore, the growing emphasis on chronic disease management and preventive care is pushing healthcare providers to utilize data analytics in their operational workflows more extensively, establishing them as the fastest-growing end-user segment in the market.

Healthcare Payers (Dominant) vs. Healthcare Providers (Emerging)

Healthcare payers are currently the dominant segment in the market, as they invest heavily in analytics to enhance their capabilities in risk assessment and patient management. This segment includes insurance companies and health plans that utilize predictive analytics to forecast healthcare trends and manage costs effectively. Their established infrastructure for data handling allows them to predict outcomes and create programs tailored to various health populations. Conversely, healthcare providers, categorized as an emerging segment, are increasingly adopting predictive analytics, focusing on individualized patient care and operational efficiencies. They face the challenge of integrating data from various sources but are rapidly enhancing their analytics capabilities to drive better health outcomes and improve operational efficiencies.

## Competitive Benchmarking

The predictive disease-analytics market is currently characterized by a dynamic competitive landscape, driven by advancements in technology, increasing demand for personalized healthcare, and the growing emphasis on data-driven decision-making. Major players such as IBM (US), Cerner Corporation (US), and Optum (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. IBM (US) focuses on integrating artificial intelligence (AI) into its analytics solutions, aiming to improve predictive capabilities and patient outcomes. Cerner Corporation (US) emphasizes partnerships with healthcare providers to develop tailored analytics solutions, thereby enhancing its service offerings. Optum (US) leverages its extensive data resources to provide actionable insights, positioning itself as a leader in the analytics space. Collectively, these strategies contribute to a competitive environment that is increasingly reliant on innovation and technological integration.Key business tactics within the market include localized service delivery and supply chain optimization, which are essential for meeting the diverse needs of healthcare providers across different regions. The competitive structure appears moderately fragmented, with several key players exerting influence while also facing competition from emerging startups. This fragmentation allows for a variety of solutions and innovations, fostering a vibrant ecosystem that encourages collaboration and competition among established firms and new entrants alike.
In October IBM (US) announced a strategic partnership with a leading healthcare provider to enhance its predictive analytics capabilities through AI integration. This collaboration aims to develop advanced algorithms that can predict patient outcomes more accurately, thereby improving care delivery. The significance of this partnership lies in its potential to set new standards in predictive analytics, positioning IBM (US) as a pioneer in the integration of AI within healthcare analytics.
In September Cerner Corporation (US) launched a new analytics platform designed to streamline data sharing among healthcare providers. This initiative is expected to facilitate better patient management and improve clinical decision-making. The strategic importance of this launch is underscored by the increasing need for interoperability in healthcare systems, which is crucial for effective predictive analytics.
In August Optum (US) expanded its analytics services by acquiring a data analytics startup specializing in machine learning. This acquisition is likely to enhance Optum's capabilities in delivering predictive insights, thereby strengthening its competitive edge. The move reflects a broader trend in the market where established players are seeking to bolster their technological capabilities through strategic acquisitions.
As of November current trends in the predictive disease-analytics market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on technological advancements and supply chain reliability rather than solely on price. This shift suggests that companies that prioritize innovation and adaptability will likely emerge as leaders in the predictive disease-analytics market.

## Recent News & Developments

In recent months, the US Predictive Disease Analytics Market has seen significant developments, notably in healthcare analytics solutions provided by companies such as SAP, SAS, and Oracle. Innovations focused on enhancing patient outcomes through predictive modeling and data analysis are gaining traction. In July 2023, Cerner was reported to have expanded its predictive analytics capabilities by integrating machine learning tools to enhance hospital operations and patient care. Furthermore, in August 2023, Allscripts announced a strategic partnership with Health Catalyst to deliver advanced data integration services which could improve clinical decision-making processes.

The investment activity in this sector remains robust, with UnitedHealth Group acquiring a stake in Inovalon in September 2023 to leverage predictive capabilities that can enhance insurance and healthcare management. Additionally, IBM's acquisition of a smaller analytics firm in June 2023 aimed to strengthen its healthcare AI portfolio, allowing for deeper patient insights. The valuation of major players in the market is increasing, with estimates suggesting a rapid growth trend, underlining the importance of predictive analytics in addressing healthcare challenges across the United States.

Recent market growth has emphasized the role of technology in managing public health data and improving responses to disease outbreaks.

## Report Scope

| MARKET SIZE 2024 | 896.91(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 984.54(USD Million) |
| MARKET SIZE 2035 | 2500.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.77% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | IBM (US), Cerner Corporation (US), Epic Systems Corporation (US), McKesson Corporation (US), Optum (US), Philips (NL), Siemens Healthineers (DE), Roche Diagnostics (CH), Allscripts Healthcare Solutions (US) |
| Segments Covered | Component, Deployment, End User |
| Key Market Opportunities | Integration of artificial intelligence in predictive disease-analytics market enhances diagnostic accuracy and patient outcomes. |
| Key Market Dynamics | Technological advancements drive predictive disease-analytics adoption, enhancing patient outcomes and influencing healthcare decision-making. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current market valuation of the US predictive disease-analytics market?**
A: The market valuation was $896.91 Million in 2024.

**Q: What is the projected market size for the US predictive disease-analytics market by 2035?**
A: The projected market size is $2500.0 Million by 2035.

**Q: What is the expected CAGR for the US predictive disease-analytics market during the forecast period 2025 - 2035?**
A: The expected CAGR is 9.77% during the forecast period 2025 - 2035.

**Q: Which companies are considered key players in the US predictive disease-analytics market?**
A: Key players include IBM, Cerner Corporation, Epic Systems Corporation, McKesson Corporation, Optum, Philips, Siemens Healthineers, Roche Diagnostics, and Allscripts Healthcare Solutions.

**Q: What are the main components of the US predictive disease-analytics market?**
A: The main components are Software & Services, valued at $600.0 Million to $1600.0 Million, and Hardware, valued at $296.91 Million to $900.0 Million.

**Q: How is the US predictive disease-analytics market segmented by deployment?**
A: The market is segmented into On-premise, valued at $300.0 Million to $800.0 Million, and Cloud-based, valued at $596.91 Million to $1700.0 Million.

**Q: What are the end-user segments in the US predictive disease-analytics market?**
A: End-user segments include Healthcare Payers and Healthcare Providers, each valued at $358.76 Million to $1000.0 Million, and Other End Users, valued at $179.39 Million to $500.0 Million.

**Q: How does the market valuation in 2024 compare to the projected valuation in 2035?**
A: The market valuation in 2024 was $896.91 Million, which is expected to grow to $2500.0 Million by 2035.

**Q: What trends are influencing the growth of the US predictive disease-analytics market?**
A: Trends include advancements in technology, increased demand for data-driven healthcare solutions, and the growing emphasis on personalized medicine.

**Q: What role do key players like IBM and Cerner Corporation play in the market?**
A: Key players like IBM and Cerner Corporation are likely to drive innovation and market growth through their advanced analytics solutions and extensive healthcare networks.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-predictive-disease-analytics-market-15655*